Amdocs Limited (NASDAQ:DOX) Expected to Announce Quarterly Sales of $1.03 Billion

Equities research analysts expect Amdocs Limited (NASDAQ:DOX) to post $1.03 billion in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Amdocs’ earnings. The highest sales estimate is $1.03 billion and the lowest is $1.02 billion. Amdocs reported sales of $1.00 billion in the same quarter last year, which indicates a positive year over year growth rate of 3%. The company is scheduled to announce its next earnings results after the market closes on Wednesday, August 7th.

According to Zacks, analysts expect that Amdocs will report full year sales of $4.09 billion for the current financial year, with estimates ranging from $4.08 billion to $4.10 billion. For the next fiscal year, analysts expect that the business will report sales of $4.21 billion, with estimates ranging from $4.19 billion to $4.24 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Amdocs.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings data on Tuesday, May 14th. The technology company reported $1.06 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.03 by $0.03. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. Amdocs had a return on equity of 15.18% and a net margin of 8.96%. Amdocs’s quarterly revenue was up 2.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.95 earnings per share.

DOX has been the subject of a number of recent research reports. ValuEngine upgraded Amdocs from a “sell” rating to a “hold” rating in a report on Wednesday, May 15th. Zacks Investment Research downgraded Amdocs from a “buy” rating to a “hold” rating and set a $67.00 price objective for the company. in a report on Tuesday, July 16th. JPMorgan Chase & Co. decreased their price objective on Amdocs from $70.00 to $67.00 and set a “neutral” rating for the company in a report on Wednesday, May 15th. TheStreet upgraded Amdocs from a “c+” rating to a “b-” rating in a report on Tuesday, June 4th. Finally, BidaskClub upgraded Amdocs from a “sell” rating to a “hold” rating in a report on Tuesday, June 11th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $70.75.

NASDAQ DOX traded down $0.83 on Friday, reaching $62.49. The company had a trading volume of 557,876 shares, compared to its average volume of 965,720. The firm has a market cap of $8.72 billion, a price-to-earnings ratio of 16.71, a price-to-earnings-growth ratio of 1.88 and a beta of 0.42. Amdocs has a fifty-two week low of $52.60 and a fifty-two week high of $67.57. The business has a 50 day moving average price of $62.86.

The company also recently declared a quarterly dividend, which was paid on Friday, July 19th. Shareholders of record on Friday, June 28th were given a dividend of $0.285 per share. The ex-dividend date was Thursday, June 27th. This represents a $1.14 dividend on an annualized basis and a yield of 1.82%. Amdocs’s dividend payout ratio (DPR) is currently 30.48%.

Institutional investors and hedge funds have recently modified their holdings of the business. FMR LLC increased its stake in Amdocs by 12.1% in the 1st quarter. FMR LLC now owns 20,412,323 shares of the technology company’s stock valued at $1,104,510,000 after buying an additional 2,203,154 shares during the last quarter. Norges Bank acquired a new position in Amdocs during the 4th quarter worth approximately $89,204,000. Wells Fargo & Company MN lifted its position in Amdocs by 28.1% during the 1st quarter. Wells Fargo & Company MN now owns 5,951,683 shares of the technology company’s stock worth $322,045,000 after acquiring an additional 1,303,903 shares in the last quarter. Beutel Goodman & Co Ltd. lifted its position in Amdocs by 41.9% during the 1st quarter. Beutel Goodman & Co Ltd. now owns 2,918,932 shares of the technology company’s stock worth $118,189,000 after acquiring an additional 862,601 shares in the last quarter. Finally, Clal Insurance Enterprises Holdings Ltd lifted its position in Amdocs by 209.1% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 1,090,517 shares of the technology company’s stock worth $59,017,000 after acquiring an additional 737,705 shares in the last quarter. 90.80% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.

See Also: Oversold

Get a free copy of the Zacks research report on Amdocs (DOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.